Laurus Labs

Laurus Labs Limited (NSE:LAURUSLABS) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

(22 Sep 2025)

Most readers would already be aware that Laurus Labs' (NSE:LAURUSLABS) stock increased significantly by 40% over the...

Read more →

Top Gainers and Losers on Sep 22: Mphasis, KFIN Tech, Redington, Voltas, Laurus Labs among top losers today

(22 Sep 2025)

The Indian stock market fell on Monday, influenced by a sell-off in tech and pharma stocks after the U.S. raised H-1B visa fees.

Read more →

BEL, Laurus Labs, IREDA: How to trade these 3 buzzing stocks

(22 Sep 2025)

Bajaj Broking said that Bharat Electronics continues to display a textbook higher–high, higher–low formation on the weekly timeframe,...

Read more →

Laurus Labs - GE Vernova T&D, among 5 stocks witness 5-year swing high breakout

(22 Sep 2025)

Last 5-Year High: Rs 926.3 | LTP: Rs 932.1 Laurus Labs.

Read more →

Laurus Labs Achieves 52-Week High Amidst Strong Financial Performance and Market Position

(20 Sep 2025)

Laurus Labs has achieved a new 52-week high stock price of Rs. 923.45, following a trend reversal after three days of decline.

Read more →

Laurus Labs soars 6% in 2 days, market cap tops ₹ 50,000 crore; here's why

(19 Sep 2025)

Laurus Labs Share Price Today, Laurus Labs Target Price: At 11:29 AM, Laurus Labs' stock was quoting 2 per cent higher at ₹943.15 on the BSE...

Read more →

State Bank of India to Laurus Labs- Prashanth Tapse of Mehta Equities suggests stocks to buy in the short term

(19 Sep 2025)

On Friday, Nifty 50 and Sensex fell due to geopolitical tensions after the US ended sanctions waivers for Iran's Chabahar Port.

Read more →

Biocon, Laurus Labs among 6 stocks that closed above VWAP

(19 Sep 2025)

On September 18, the closing prices of six stocks in the Nifty500 pack ended over 1% higher than their VWAP (Volume Weighted Average Price),...

Read more →

Stock Picks Today: Sun Pharma, ICICI Bank, Bajaj Finance, Afcons, Yes Bank, Laurus Labs On Brokerages Radar

(18 Sep 2025)

Sun Pharmaceuticals Ltd., Bajaj Finance Ltd., Afcons Infrastructure Ltd., ICICI Bank Ltd., Yes Bank Ltd., Avenue Supermarts Ltd.,...

Read more →

Sun Pharma, IndusInd Bank, Aditya Birla Capital, Laurus Labs, Samvardhana Motherson: BUY, SELL or HOLD stocks today

(18 Sep 2025)

Top brokerages roll out fresh BUY, SELL, and HOLD calls with new targets, spotlight on Sun Pharma, Aditya Birla Capital, Laurus Labs,...

Read more →

Goldman Sachs retains 'Sell' call on Laurus Labs, shares target

(18 Sep 2025)

Goldman Sachs valued Laurus Labs at P/E of 40 times, which is at 15-20 per cent discount to the largest domestic CRDMO players such as...

Read more →

Divi’s, Cohance, Sai Life among Jefferies’ top picks in pharma sector; Laurus Labs rated underperform

(15 Sep 2025)

India's CRDMO sector is set for growth in the next 3-5 years, with Jefferies highlighting four stocks including Divi's Labs, Sai Life are...

Read more →

Laurus Labs, Piramal, Divis, Sai Life, Cohance: Jefferies tests interest in CRDMO stocks

(13 Sep 2025)

Laurus Labs is seen as having robust near-term prospects in CRDMO, but the absence of guidance creates uncertainty.

Read more →

Laurus Labs Ltd soars 1.7%

(01 Sep 2025)

Laurus Labs Ltd is quoting at Rs 874.75, up 1.7% on the day as on 12:49 IST on the NSE. The stock is up 83.93% in last one year as compared...

Read more →

Laurus Labs to Participate in Motilal Oswal Investor Conference on Sept 2

(25 Aug 2025)

Laurus Labs announced that it will participate in the Motilal Oswal 21st Annual Global Investor Conference on September 2, 2025, in Mumbai.

Read more →

Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's

(25 Aug 2025)

Jefferies is optimistic on India's CRDMO sector, given its evolution from quasi-chemical firms into strategic partners for innovators;...

Read more →

LAURUSLABS Outlook for the Week (August 25, 2025 – August 29, 2025)

(23 Aug 2025)

Technically, Laurus Labs share price will see immediate support at 859.98 and immediate resistance would be seen at 896.63.

Read more →

Laurus Labs to dissolve CDMO arm Laurus Synthetics as part of rejig

(22 Aug 2025)

India Business News: HYDERABAD: In a restructuring exercise, Laurus Labs is demerging Unit-1, which is the API manufacturing portion of its...

Read more →

Laurus Labs announces restructuring plan to dissolve subsidiary Laurus Synthesis

(22 Aug 2025)

The company said the restructuring would improve operational integration, financial strength and business flexibility across the group.

Read more →

PG Electroplast, Laurus Labs among 7 stocks that closed above VWAP

(22 Aug 2025)

On August 21, seven stocks in the Nifty500 pack closed more than 1% above their VWAP (Volume Weighted Average Price), suggesting a potential...

Read more →

Laurus Labs Board Approves Composite Scheme of Arrangement

(22 Aug 2025)

Laurus Labs (LAURUSLABS.NS) announced a Composite Scheme of Arrangement, subject to regulatory approvals, following a Board meeting on...

Read more →

Laurus Labs - Midcap Marvels: 13 stocks with high FII holding soar up to 80% in just 4 months

(16 Aug 2025)

Shares moved up 34%, rising from Rs 614 to Rs 821. FIIs held 25.70% in the June quarter. Laurus Labs.

Read more →

Laurus Labs climbs on robust Q1 earnings

(12 Aug 2025)

(28 Jul 2025, 14:46). Laurus Labs climbs on robust Q1 earnings. Laurus Labs jumped 6.44% to Rs 892.05 after the company's consolidated net profit zoomed...

Read more →

Laurus Labs Posts Strong Q1FY25-26, Maintains Growth Outlook on CDMO Momentum, Formulations Recovery

(12 Aug 2025)

Laurus Labs (Laurus), a Hyderabad-based pharma major, is scripting a remarkable growth story—one marked by innovation, strategic expansion...

Read more →

Laurus Labs' (NSE:LAURUSLABS) five-year total shareholder returns outpace the underlying earnings growth

(10 Aug 2025)

Long term investing can be life changing when you buy and hold the truly great businesses. While the best companies are...

Read more →

Hero Moto, Laurus Labs, Dalmia Bharat: 3 stocks to buy for short-term gains

(08 Aug 2025)

An analyst from Master Capital said that Hero MotoCorp has witnessed a breakout from a classic inverse head and shoulders pattern on the...

Read more →

Laurus Labs Stock Rallies Over 6% on ₹5,630 Cr Pharma Zone Expansion

(31 Jul 2025)

Laurus Labs shares surge 6.7% to ₹893.90 after Andhra Pradesh allots 531 acres for ₹5630 Cr pharma zone. Project to create 6350 jobs;...

Read more →

Laurus Labs shares in focus again post 1,185% rise in Q1 net profit

(31 Jul 2025)

Shares of Laurus Labs are in focus today after the pharma firm said the Andhra Pradesh government allotted 531.77 acre in IP Rambilli...

Read more →

Laurus Labs shares are at a 52-week high but analysts still see 33% downside

(30 Jul 2025)

Shares of Laurus Labs Ltd., which hit a fresh 52-week high on Monday, July 28, can decline up to 33%, as per analysts who track the stock...

Read more →

Laurus Labs shares jump over 7% after securing land allotment in Andhra Pradesh

(30 Jul 2025)

Laurus Labs stock price increased following Andhra Pradesh government's land allotment. The company will establish Laurus Pharma Zone in...

Read more →

Laurus Labs to invest €5 million in JV KRKA Pharma

(30 Jul 2025)

The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing...

Read more →

Laurus Labs Faces Short-Term Decline Despite Strong Long-Term Performance Metrics

(30 Jul 2025)

Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, saw a decline today despite reaching a new 52-week high earlier.

Read more →

Buy Or Sell: Cipla, SBI Life, Laurus Lab Are Nilesh Jains Top Picks—Check Target Prices

(28 Jul 2025)

Nilesh Jain, Head AVP-Technical & Derivatives Research (Equity Research), Centrum Broking Ltd., has recommended three stocks for investors...

Read more →

Laurus Labs Q1 PAT Surges 13x YoY to ₹162 Cr on 31% Revenue Rise

(26 Jul 2025)

Hyderabad, July 25, 2025 — Laurus Labs Ltd (NSE: LAURUSLABS, BSE: 540222) delivered a significant turnaround in Q1 FY26, with consolidated...

Read more →

Laurus Labs to set up Phama Zone in Andhra Pradesh with ₹5,630 crore

(26 Jul 2025)

Laurus Labs to invest ₹5630 crore in Andhra Pradesh for Pharma Zone, creating jobs and securing land for expansion.

Read more →

Macro Trends and Their Impact on Laurus Labs Limited (LAURUSLABS) - Dynamic capital growth

(24 Jul 2025)

【Market Discussions】✌️ From pre-market analysis to post-close earnings plays, we offer full-cycle investment insights — empowering traders...

Read more →

Laurus Labs, Swan Energy to Delhivery — These 13 small-cap stocks have surged up to 23% in a month. Do you own any?

(24 Jul 2025)

Small-cap stocks: Laurus Labs led the gains in the Nifty Smallcap 100 index, with a rise of over 23% in a month and a 45.3% surge from its...

Read more →

Laurus Labs Limited (540222) Stock Rallies - Market-crushing profits

(23 Jul 2025)

Laurus Labs Limited (540222) Stock Rallies ✌️【Stock Analysis】✌️ Your path to 200% returns starts with our exclusive stock recommendations...

Read more →

Laurus Labs Limited (540222) Stock Rallies - Superior returns

(22 Jul 2025)

Laurus Labs Limited (540222) Stock Rallies ✌️【Market Discussions】✌️ Stock group predictions and real-time quotes for global stocks,...

Read more →

Is Laurus Labs Limited (LAURUSLABS) a Good Long Term Bet - Exceptional return forecasts

(22 Jul 2025)

【Stock Watchlist】✌️ Our system filters through market noise and pinpoints trades that deliver the highest return on risk — typically 200%+.

Read more →

Laurus Labs Limited (LAURUSLABS) Hits 52 Week High - Free Investment Community

(22 Jul 2025)

【Stock Watchlist】✌️ Our members enjoy access to high-conviction investment opportunities identified through rigorous quantitative screening...

Read more →

Laurus Labs Limited (LAURUSLABS) Announces Strategic Shift - Triple-digit returns

(21 Jul 2025)

Laurus Labs Limited (LAURUSLABS) Announces Strategic Shift ✌️【Trading Ideas】✌️ Real data. Real results. Our top picks deliver massive growth...

Read more →

Revenues Tell The Story For Laurus Labs Limited (NSE:LAURUSLABS) As Its Stock Soars 28%

(21 Jul 2025)

The Laurus Labs Limited ( NSE:LAURUSLABS ) share price has done very well over the last month, posting an excellent...

Read more →

Laurus Labs share price surges over 18% in June, outperforms Sensex. What's next for this pharma stock?

(14 Jul 2025)

Laurus Labs shares rose over 2% in Monday's trading, marking three days of gains. In June 2025, the stock has gained 18%, outperforming the...

Read more →

Laurus Labs Achieves 52-Week High Amid Strong Financial Performance and Market Trends

(03 Jul 2025)

Laurus Labs has reached a new 52-week high, reflecting its strong market performance and impressive financial metrics.

Read more →

Laurus up for 9th straight day, soars 23% in 1 month. What's driving stock?

(03 Jul 2025)

Laurus Labs Share price: Scale-up of the CDMO segment in FY26, is expected to contribute meaningfully to revenue growth and margin expansion...

Read more →

Laurus Labs Conducts 20th AGM with Key Stakeholders

(27 Jun 2025)

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has issued an announcement. Laurus Labs Ltd. held its 20th Annual General Meeting (AGM) on June 26,...

Read more →

Laurus Labs Ltd spurts 1.63%, up for five straight sessions

(26 Jun 2025)

Laurus Labs Ltd is quoting at Rs 680.9, up 1.63% on the day as on 12:44 IST on the NSE. The stock is up 60.78% in last one year as compared...

Read more →

Laurus Labs Asked to Submit Justification, Data for Pediatric Darunavir-Ritonavir FDC Proposal

(24 Jun 2025)

New Delhi: The Subject Expert Committee (SEC) on Antimicrobial & Antiviral under the Central Drugs Standard Control Organisation (CDSCO) has...

Read more →

LAURUSLABS Outlook for the Week (June 23, 2025 – June 27, 2025)

(22 Jun 2025)

Technically, Laurus Labs share price will see immediate support at 633.70 and immediate resistance would be seen at 675.65.

Read more →

Laurus Labs Achieves 52-Week High Amid Strong Financial Performance and Market Confidence

(11 Jun 2025)

Laurus Labs has achieved a new 52-week high, reflecting a significant increase in stock performance over the past year.

Read more →

Investors Shouldn't Be Too Comfortable With Laurus Labs' (NSE:LAURUSLABS) Earnings

(11 Jun 2025)

Unsurprisingly, Laurus Labs Limited's ( NSE:LAURUSLABS ) stock price was strong on the back of its healthy earnings...

Read more →

Dr Reddy's, Laurus Labs, other pharma stocks jump up to 3% amid bullish brokerage calls, other triggers

(08 Jun 2025)

The Nifty Pharma index is currently the top gaining sectoral index on NSE, rising over 1 percent to hover around 21586.80.

Read more →

Laurus Labs Shows Strong Performance Amid Elevated Valuation Metrics and Bullish Indicators

(08 Jun 2025)

Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment reflecting changes in its technical...

Read more →

5 Best CDMO Stocks in India

(07 Jun 2025)

A CDMO, (Contract Development and Manufacturing Organisation), is a company that provides comprehensive services to pharmaceutical,...

Read more →

LAURUSLABS Outlook for the Week (June 09, 2025 – June 13, 2025)

(06 Jun 2025)

Technically, Laurus Labs share price will see immediate support at 615.63 and immediate resistance would be seen at 659.03.

Read more →

Mahindra & Mahindra, Laurus Labs —Check Shrikant Chouhans Top Picks

(27 May 2025)

Computer Age Management Services Ltd., Mahindra & Mahindra Ltd., and Laurus Labs Ltd. have 'buy' recommendation from Shrikant Chouhan,...

Read more →

Stocks To Buy: Action Construction, Computer Age Management, Container Corp, Jubilant Pharmova, Laurus Labs

(27 May 2025)

Analysts chose Action Construction Equipment Ltd., Container Corp. of India, Jubilant Pharmova, Computer Age Management Services Ltd.,...

Read more →

LAURUSLABS Outlook for the Week (May 26, 2025 – May 30, 2025)

(23 May 2025)

Technically, Laurus Labs share price will see immediate support at 578.42 and immediate resistance would be seen at 614.27.

Read more →

Laurus Labs Reports Significant Profit Growth and Strong Financial Metrics Amid Market Evaluation

(20 May 2025)

Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, recently experienced an evaluation adjustment due to its strong financial...

Read more →

Laurus Labs (NSE:LAURUSLABS) Has A Pretty Healthy Balance Sheet

(19 May 2025)

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility...

Read more →

LAURUSLABS Outlook for the Week (May 19, 2025 – May 23, 2025)

(16 May 2025)

Technically, Laurus Labs share price will see immediate support at 581.68 and immediate resistance would be seen at 618.68.

Read more →

Laurus Labs: Bold Outlook for FY25-26

(15 May 2025)

Laurus Labs (Laurus), a Hyderabad-based pharma major, is scripting a remarkable growth story—one marked by innovation, strategic expansion...

Read more →

Cipla, Lupin, Zydus Life, Laurus Labs, Mankind Under Pressure: What's Dragging Pharma Stocks Down Today

(06 May 2025)

Pharma stocks are under pressure during Tuesdays trading session after United States President Donald Trump announced an executive order to...

Read more →

LAURUSLABS Outlook for the Week (May 05, 2025 – May 09, 2025)

(02 May 2025)

Technically, Laurus Labs share price will see immediate support at 601.25 and immediate resistance would be seen at 639.70.

Read more →

Laurus Labs Limited Just Recorded A 7.2% EPS Beat: Here's What Analysts Are Forecasting Next

(29 Apr 2025)

Laurus Labs Limited ( NSE:LAURUSLABS ) last week reported its latest yearly results, which makes it a good time for...

Read more →

Laurus Labs Limited (NSE:LAURUSLABS) Not Flying Under The Radar

(27 Apr 2025)

Laurus Labs Limited (NSE:LAURUSLABS) Not Flying Under The Radar ... When close to half the companies in the Pharmaceuticals industry in India have...

Read more →

Laurus Labs bets on cell and gene therapies, eyes CDMO role

(26 Apr 2025)

Laurus Labs is aggressively investing in cell and gene therapies, looking to become a key manufacturing partner in the burgeoning field.

Read more →

Laurus Labs falls 6% despite strong Q4 results: Here's what brokerages say

(26 Apr 2025)

Fall in Laurus Labs Share, Q4 results 2025: Laurus Labs stock was quoting at ₹618.50, down 4.18 per cent from the previous session's closing...

Read more →

Laurus Labs shares drop 3% despite 2nd straight quarterly beat; here're target prices

(26 Apr 2025)

Laurus Labs share: The stock fell 3.22 per cent to Rs 626.25 on BSE. Jefferies maintained its 'Underperform' on Laurus with a target of Rs...

Read more →

Laurus Labs Q4 Results: Second straight quarter of margin over 20%; Co expects higher revenue in FY26

(22 Apr 2025)

Laurus Labs Ltd. reported results for the January-March quarter that were either in-line or higher than expectations.

Read more →

Laurus Labs Q4 Results: Profit Rises 200% To Rs 234 Crore, Beats Estimates

(22 Apr 2025)

Laurus Labs Ltd.'s fourth-quarter profit rose to Rs 234 crore, beating analysts' estimates. The net profit of the Hyderabad-based pharma and...

Read more →

Laurus Labs Q4 Results: Profit soars 3-fold to Rs 234 crore; revenue at Rs 1,440 crore

(22 Apr 2025)

Drug firm Laurus Labs on Thursday said its consolidated profit increased three-fold to Rs 234 crore for the March quarter, driven by strong...

Read more →

Laurus Labs To Invest Rs 5,000 Crore In New Bulk Drug Unit In Andhra Pradesh

(20 Apr 2025)

Amaravati: Hyderabad-based multinational pharmaceutical and biotechnology company Laurus Labs Limited has signed an agreement with the...

Read more →

Laurus Labs’ API plant in Vizag gets EIR from U.S. FDA

(15 Apr 2025)

Laurus Labs' API manufacturing facility in Visakhapatnam receives establishment inspection report from US FDA after inspection.

Read more →

Laurus Labs to invest ₹5,000 crore in new manufacturing plant in Andhra Pradesh

(06 Apr 2025)

Laurus Labs will invest ₹5,000 crore in Anakapalli district of Andhra Pradesh to set up a state-of-the-art manufacturing facility,...

Read more →

Laurus Labs to invest ₹5,000 crore in A.P

(03 Apr 2025)

The Laurus Labs is set to establish a bulk drugs manufacturing unit with an investment of approximately ₹5,000 crore at IP Rambilli Phase-2,...

Read more →

Laurus Labs to invest ₹833 crore in JV with Slovenian firm

(06 Mar 2025)

Drug firm Laurus Labs Ltd on Thursday (March 6) said it has approved an ₹833-crore investment in KRKA Pharma Private Limited,...

Read more →

Laurus Labs Ltd soars 3.43%, up for third straight session

(05 Mar 2025)

Laurus Labs Ltd rose for a third straight session today. The stock is quoting at Rs 564.2, up 3.43% on the day as on 12:49 IST on the NSE. The...

Read more →

Laurus Labs Ltd down for fifth straight session

(14 Feb 2025)

Laurus Labs Ltd is quoting at Rs 546.75, down 9.03% on the day as on 13:19 IST on the NSE. The stock jumped 39.28% in last one year as...

Read more →

Laurus Labs share price zooms 10% after getting THIS US relief. Do you own?

(30 Jan 2025)

Laurus Labs Ltd. shares jumped by up to 10 per cent on Thursday, January 30, following the US approval of an "emergency humanitarian waiver."

Read more →

Laurus Labs shares down 15% on profit booking post Q3 earnings; Should you buy or sell?

(27 Jan 2025)

Goldman Sachs has retained its 'Sell' rating on Laurus Labs, setting a price target of ₹475. The brokerage noted that although the...

Read more →

Here is why Laurus Labs shares are down 15% on Monday

(27 Jan 2025)

Shares of Laurus Labs Ltd. are down 15% on Monday, January 27, giving up all the gains it had made during Friday's trading session.

Read more →

Laurus Labs Stock Declines 3.5% on January 15, Underperforming Sector by 3.2%

(16 Jan 2025)

Laurus Labs, a prominent player in the pharmaceuticals and drugs sector, experienced a decline of 3.5% on January 15, 2025.

Read more →

I-T Dept imposes Rs 3.86 cr penalty on Laurus Labs for disallowed deduction

(15 Jan 2025)

Laurus Labs further clarified that the penalty proceedings would not have any financial impact on the company.

Read more →

Laurus Labs Limited's (NSE:LAURUSLABS) P/S Is On The Mark

(02 Jan 2025)

When close to half the companies in the Pharmaceuticals industry in India have price-to-sales ratios (or "P/S") below...

Read more →

Laurus Labs Ltd gains for fifth session

(02 Jan 2025)

Laurus Labs Ltd is quoting at Rs 590.25, up 0.61% on the day as on 12:44 IST on the NSE. The stock is up 36.3% in last one year as compared to a 9.49% gain

Read more →

Buy Laurus Labs, target price Rs 710: Bajaj Broking

(27 Dec 2024)

Bajaj Broking recommends buying Laurus Labs with a target price of Rs 710. The current price is Rs 565.4. Laurus Labs expects significant...

Read more →

Stocks in news: UltraTech, RIL, TCS, Vedanta, NTPC Green, IOC, Auro Pharma & Laurus Labs

(24 Dec 2024)

Stocks including UltraTech Cement, Reliance Industries, Tata Consultancy Services, NTPC Green, Indian Oil, Aurobindo Pharma, Laurus Labs and...

Read more →

Stock Radar: NTPC Green Energy, TCS, TeamLease, UltraTech Cement, Laurus Labs, Aurobindo Pharma, HCC in...

(23 Dec 2024)

Stocks To Watch for Dec 23: Stocks like Fortis Healthcare, Laurus Labs, India Cements, Tata Consultancy Services, Dalmia Bharat, Vedanta,...

Read more →

Laurus Labs - HUDCO among 5 stocks set to soar in 2025: Bajaj Broking

(23 Dec 2024)

Laurus Labs, a pharmaceuticals player, is poised for a strong rebound in 2025. With a market capitalization of Rs 30570.33 crore,...

Read more →

Briefs: Laurus Bio and Cupid

(22 Dec 2024)

Laurus Labs informs that Eight Roads Ventures and F-Prime Capital (Investors) have together invested Rs. 120 crores in Laurus Bio.

Read more →

LAURUSLABS Outlook for the Week

(21 Dec 2024)

Technically, Laurus Labs share price will see immediate support at 550.73 and immediate resistance would be seen at 573.23.

Read more →

Pharma stocks buck weak market; Dr Reddy's Labs, Cipla, Lupin up 1-4%

(19 Dec 2024)

Broad-based gains across most pharmaceutical stocks propelled the Nifty Pharma index over 1 percent higher, making it the sole sectoral...

Read more →

Stocks To BUY Intraday, Top Recommendations: ICICI Bank, Power Grid, RIL, Indian Hotels, KPR Mill, Laurus Labs

(16 Dec 2024)

Intraday Stocks To BUY Today: Market experts Nooresh Merani and Kunal Bothra have recommended six stocks to buy today for intraday trade.

Read more →

This pharma stock made investors nearly 200% wealthier in a year, Goldman Sachs suggests buying more

(13 Dec 2024)

Goldman Sachs says it continues to prefer Syngene and Neuland over Divi's, on which it has a neutral call, and Gland Pharma and Laurus Labs,...

Read more →

Laurus Labs Limited's (NSE:LAURUSLABS) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

(12 Dec 2024)

Laurus Labs (NSE:LAURUSLABS) has had a great run on the share market with its stock up by a significant 16% over the...

Read more →

Laurus Labs Limited announced that it expects to receive INR 1.2 billion in funding from Eight Roads Ventures India

(10 Dec 2024)

Laurus Labs Limited announced a private placement that it will issue equity shares for the aggregate gross proceeds of up to INR 1200000000 on December 6,...

Read more →

Shares to buy or sell: Rajesh Palviya of Axis Securities suggests these three stocks to buy, hold and accumulate today

(10 Dec 2024)

Rajesh Palviya has recommended to buy, hold, and accumulate Laurus Labs Ltd, Polycab India Ltd, and Siemens Ltd.

Read more →

Stocks To Watch: Paytm, Godrej Consumer, JSW Energy, Bansal Wire, Laurus Labs

(09 Dec 2024)

Paytm parent firm One 97 Communications Ltd., Ceat Ltd. and Godrej Consumer Products Ltd. will be the stocks in focus before going into...

Read more →

Stocks to Watch: Suven Pharma, Reliance Power, Laurus Labs, Paytm, and more | Stock Market News

(09 Dec 2024)

Suven Pharmaceuticals: Suven Pharmaceuticals Limited has acquired a 56 percent controlling stake in NJ Bio Inc, a US-based Contract Research...

Read more →

LAURUS LABS Share Price Today Down 5%

(09 Dec 2024)

LAURUS LABS share price has plunged 5% and is presently trading at Rs 558.7. Meanwhile, the BSE HEALTHCARE index is at 44,207.1 (down 0.7%).

Read more →

CDMO shares under pressure; Neuland, Laurus, Syngene tank up to 12%

(09 Dec 2024)

Thus far in the calendar year 2024 (CY24), the market price of Neuland Laboratories has zoomed 216%, Piramal Pharma (88%), Divi's Labs (53%)...

Read more →

Stocks to Watch: Suven Pharma, Reliance Power, Laurus Labs, Paytm, and more

(09 Dec 2024)

Suven Pharmaceuticals: Suven Pharmaceuticals Limited has acquired a 56 percent controlling stake in NJ Bio Inc, a US-based Contract Research...

Read more →

Laurus Bio secures equity infusion of Rs 120 crore

(08 Dec 2024)

Hyderabad: Laurus Labs Ltd. has announced that its subsidiary, Laurus Bio, has signed a definitive agreement for an equity investment of Rs...

Read more →

Eight Roads Ventures, F-Prime investing $14 mn in Laurus Labs unit

(07 Dec 2024)

Indian pharmaceuticals company Laurus Labs Ltd said Friday it is raising equity investment for its biotech unit from ...

Read more →

Laurus Bio secures 120 cr investment

(07 Dec 2024)

Hyderabad: Laurus Bio, a subsidiary of Hyderabad-based biopharma player Laurus Labs Ltd, has secured an equity investment of Rs 120 crore...

Read more →

Laurus Labs arms gets invt from Eight Roads Ventures, F-Prime Capital

(07 Dec 2024)

Laurus Labs announced that its subsidiary, Laurus Bio, has secured an equity investment of Rs 120 crore from Eight Roads Ventures and...

Read more →

Laurus Labs board approves investment of ₹40 crore in arm Laurus Bio

(06 Dec 2024)

Shares of Laurus Labs Ltd ended at ₹590.55, up by ₹2.40, or 0.41% on the BSE.

Read more →

Eight Roads Ventures, F-Prime Capital To Infuse Rs 120 Crore Into Laurus Labs Arm

(06 Dec 2024)

Eight Roads Ventures and F-Prime Capital will invest Rs 120 crore in Laurus Bio for manufacturing expansion, with Laurus Labs adding Rs 40...

Read more →

Laurus Labs biotech unit raises Rs 120 crore from Eight Roads Ventures

(06 Dec 2024)

Laurus Bio has secured ₹120 crore in equity investment from Eight Roads Ventures and F-Prime Capital, with Laurus Labs co-investing ₹40...

Read more →

LBL signs Rs 120 Cr investment from ERV and F-PC

(06 Dec 2024)

Hyderabad: Laurus Labs Ltd today announced that its subsidiary, Laurus Bio, has signed an agreement for equity investment of ₹ 120 Cr from...

Read more →

Laurus Labs arm inks pact to secure ₹120 crore investment

(06 Dec 2024)

Laurus Labs subsidiary Laurus Bio secures ₹120 crore investment for fermentation-based manufacturing expansion from Eight Roads Ventures and...

Read more →

Laurus Labs Hits 52-Week High, Continues to Outperform in Pharmaceutical Industry

(06 Dec 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, has recently hit a 52-week high on December 5th, 2024.

Read more →

Laurus Labs Ltd spurts 0.27%, rises for fifth straight session

(04 Dec 2024)

Laurus Labs Ltd is quoting at Rs 582.25, up 0.27% on the day as on 12:44 IST on the NSE. The stock is up 54.71% in last one year as compared...

Read more →

Laurus Labs - These 6 midcap stocks hit 52-week high, rallied up to 20% in a month

(03 Dec 2024)

New 52-week high: Rs 588 CMP: Rs 580.5.In the last one month, stock has gained about 16%. Laurus Labs.

Read more →

Laurus Labs' Stock Hits 52-Week High, Showcasing Strong Growth and Performance

(03 Dec 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, has recently reached a new milestone as its stock price hit a 52-week high on...

Read more →

Laurus Labs: Engages with Jefferies in healthcare investor meet

(02 Dec 2024)

The shares of Laurus Labs Limited were trading at ₹580.05 up by ₹12.90 or 2.27 per cent on the NSE today at 10.55 am.

Read more →

Aegis Logistics, Laurus Labs, Piramal Ent & Medanta: What Axis Securities says on these 4 stocks

(02 Dec 2024)

On the technical play, the domestic brokerage prefers three counters -- namely Aegis Logistics Ltd, Laurus Labs Ltd and Piramal Enterprises...

Read more →

Laurus Labs Ltd soars 1.78%, rises for third straight session

(02 Dec 2024)

Laurus Labs Ltd is quoting at Rs 577.25, up 1.78% on the day as on 12:49 IST on the NSE. The stock is up 52.21% in last one year as compared...

Read more →

Laurus Labs Stock Sees Positive Trend, Outperforms Sector and Sensex

(29 Nov 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, has seen a positive trend in its stock performance. On November 29, 2024,...

Read more →

Where Will Laurus Labs Stock Be in 3 Years?

(27 Nov 2024)

What is the outlook for the stock of Laurus Labs? Find out...

Read more →

Laurus Labs' Stock Hits 52-Week High, Outperforms Sensex in Past Year

(27 Nov 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, has recently reached a new milestone with its stock price hitting a 52-week high on...

Read more →

Laurus Labs - These 5 stocks hit 52-week highs, rallied up to 17% in a month

(27 Nov 2024)

New 52-week high: Rs 554.9CMP: Rs 544.3.In the last one month, stock has gained about 17%. Laurus Labs.

Read more →

Laurus Labs Ltd soars 0.35%, rises for fifth straight session

(26 Nov 2024)

Laurus Labs Ltd is quoting at Rs 533.9, up 0.35% on the day as on 12:44 IST on the NSE. The stock is up 44.01% in last one year as compared...

Read more →

Laurus Labs Hits 52-Week High, Outperforms Sensex in Pharmaceutical Industry

(26 Nov 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, has recently reached a new milestone as its stock price hit a...

Read more →

ICICI Bank, Laurus Labs, Mastek & Ashok Leyland: These are 4 stock picks from SMC Global

(25 Nov 2024)

SMC Global said that Ashok Leyland has been trading lower as prices witness a corrective phase from its 52-week high of Rs 264 levels till...

Read more →

Laurus Labs' Stock Performance Continues to Soar, Outperforming Sector and Setting New Highs

(25 Nov 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, has seen a positive trend in its stock performance. On November 25th, 2024,...

Read more →

Top Stock Picks: Hero Motocorp, Eicher Motors, BHEL, Bajaj Finance, Indian Hotels and Laurus Labs on the radar

(25 Nov 2024)

Top Stock Picks: On Monday, market tech analysts Vishal Malkan, Nagaraj Shetti, Mitessh Thakkar and F&O analyst Chandan Taparia recommended...

Read more →

Laurus Labs - These 6 NSE F&O stocks saw a high increase in futures open interest

(25 Nov 2024)

OI: 2,33,47800 | Chg OI: 20,12800 | Chg OI (%): 9.43 Laurus Labs.

Read more →

Tech Mahindra, Paytm hit 52-week high as NIFTY50, SENSEX see strong gain for the second straight day

(25 Nov 2024)

Shares of One 97 Communications Ltd, the parent firm of fintech player Paytm, surged as much as 4.2% to hit its 52-week high of ₹939 apiece...

Read more →

Laurus Labs Share Price Close to Yearly Highs; Fibonacci Levels & Technical Analysis Suggest Bullish Breakout

(24 Nov 2024)

Laurus Labs, a major player in the pharmaceutical and biotechnology space, has been gaining traction among investors due to its strong...

Read more →

T’gana pharma biggies to inject 5,200cr in Pharma City, create over 12,000 jobs

(23 Nov 2024)

Top pharmaceutical companies in Telangana, including Laurus Labs and Gland Pharma, are set to invest ₹5260 crore in the Pharma City project...

Read more →

Laurus Labs Ltd soars 5.04%, rises for third straight session

(22 Nov 2024)

Laurus Labs Ltd is quoting at Rs 513.8, up 5.04% on the day as on 12:49 IST on the NSE. The stock is up 39.11% in last one year as compared...

Read more →

Laurus Labs Ltd.

(22 Nov 2024)

We offer cutting-edge synthesis services trusted by leading research labs and companies worldwide. Innovative, robust and scalable chemistry is the core...

Read more →

Laurus Labs Limited (NSE:LAURUSLABS) most popular amongst retail investors who own 34% of the shares, institutions hold 33%

(21 Nov 2024)

Key Insights Significant control over Laurus Labs by retail investors implies that the general public has more power to...

Read more →

Laurus Labs: Steps up focus on R&D, lines up 62 products

(04 Nov 2024)

Laurus Labs opened its new small molecule R&D centre at ICICI Knowledge Park, Hyderabad, in October which facilitates one-stop development...

Read more →

Muhurat Trading 2024 stock: JM Financial's Soni Patnaik picks Laurus Labs - Check target

(01 Nov 2024)

Muhurat Trading 2024 will commence shortly, which will remain between 6:00 PM to 7:00 PM. It allows investors to trade in equities,...

Read more →

Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.40

(28 Oct 2024)

The board of Laurus Labs Limited ( NSE:LAURUSLABS ) has announced that it will pay a dividend on the 23rd of November...

Read more →

Laurus Labs' Stock Performance Soars, Outperforms Sector and Sensex on October 28th

(28 Oct 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, has seen a positive trend in its stock performance on October 28th,...

Read more →

Laurus Labs CEO Believes CDMO, API Business To Be Growth Drivers In Second Half

(28 Oct 2024)

Hyderabad-based Laurus Labs' Founder and Chief Executive Officer Dr Satyanarayana Chava believes that the contract development and...

Read more →

Laurus Labs posts Q2 FY25 consolidated PAT at Rs. 19.84 Cr

(28 Oct 2024)

Laurus Labs has reported total income of Rs. 1228.30 crores during the period ended September 30, 2024.

Read more →

Accumulate Laurus Labs; target of Rs 489: KR Choksey

(28 Oct 2024)

KR Choksey recommended Accumulate rating on Laurus Labs with a target price of Rs 489 in its research report dated October 25, 2024.

Read more →

Buy Laurus Labs; target of Rs 530: Motilal Oswal

(27 Oct 2024)

Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 530 in its research report dated...

Read more →

Laurus Labs (NSE:LAURUSLABS) Takes On Some Risk With Its Use Of Debt

(26 Oct 2024)

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to...

Read more →

Laurus Labs Q2 net slumps to ₹17.72 crore

(25 Oct 2024)

Laurus Labs reports 55% decline in net profit, flat revenue; CEO remains optimistic about growth opportunities in H2.

Read more →

Laurus Labs Ltd leads gainers in 'A' group

(25 Oct 2024)

Gateway Distriparks Ltd, Bikaji Foods International Ltd, PNB Housing Finance Ltd and DCB Bank Ltd are among the other gainers in the BSE's...

Read more →

Laurus Labs, PNB Housing shares rallied up to 11% today; here are target prices

(25 Oct 2024)

Shares of Laurus Labs climbed 7.38 per cent to hit a high of Rs 478.95. PNB Housing Finance shares, on the other hand, surged 10.90 per cent...

Read more →

Laurus Labs shares rise despite weak Q2, analysts say valuations expensive

(25 Oct 2024)

Shares of Laurus Labs Ltd. were trading with gains of as much as 6% on Friday, even after reporting another weak performance for the...

Read more →

Laurus Labs' Stock Price Rises 3.3% in Line with Sector Performance

(25 Oct 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, saw a 3.3% increase in its stock price on October 25th, 2024. This rise in stock...

Read more →

Laurus Labs Standalone September 2024 Net Sales at Rs 1,184.85 crore, up 2.32% Y-o-Y

(25 Oct 2024)

Reported Standalone quarterly numbers for Laurus Labs are:Net Sales at Rs 1,184.85 crore in September 2024 up 2.32% from Rs. 1,158.03 crore...

Read more →

Laurus Labs Consolidated September 2024 Net Sales at Rs 1,223.70 crore, down 0.06% Y-o-Y

(25 Oct 2024)

Quarterly Net Profit at Rs. 19.84 crore in September 2024 down 46.31% from Rs. 36.95 crore in September 2023. EBITDA stands at Rs. 182.93...

Read more →

Laurus Labs Q2 net down 46% at ₹20 cr

(24 Oct 2024)

Laurus Labs reports 46% decrease in net profit, flat revenue in Q2 2024, focusing on customer needs for value.

Read more →

Laurus Labs Q2 Results | Net profit dives 47% to ₹20 crore, declares dividend; misses estimates

(24 Oct 2024)

Shares of Laurus Labs Ltd ended at ₹450.35, up by ₹1.00, or 0.22% on the BSE.

Read more →

Laurus Labs Q2 Results: Net Profit Down 46%, Misses Estimates

(24 Oct 2024)

Laurus Labs Ltd.'s second-quarter profit declined, missing analysts' estimates. Net profit of the Hyderabad-based pharma and biotech company...

Read more →

Laurus Labs consolidated net profit declines 46.31% in the September 2024 quarter

(24 Oct 2024)

Net profit of Laurus Labs declined 46.31% to Rs 19.84 crore in the quarter ended September 2024 as against Rs 36.95 crore during the previous quarter ended...

Read more →

Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

(24 Oct 2024)

Laurus Labs Limited reported earnings results for the second quarter and six months ended September 30, 2024. For the second quarter,...

Read more →

Laurus Labs Q2 results: Net down 46% at ₹20 cr

(24 Oct 2024)

Laurus Labs posted a 46 per cent decrease in its net profit in the second quarter ended September 2024 at ₹20 crore as against ₹37 crore...

Read more →

Laurus Labs Stock Shows Positive Trend, Outperforms Sector by 3.02%

(18 Oct 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, saw a positive trend in its stock performance on October 18, 2024.

Read more →

Laurus Labs - Hindalco, Eicher Motors among 5 stocks with long buildup

(18 Oct 2024)

OI change on October 18: 2.37%Change in stock price: 2.55% Laurus Labs.

Read more →

Laurus Labs Ltd soars 0.94%, up for fifth straight session

(14 Oct 2024)

Laurus Labs Ltd is quoting at Rs 478.6, up 0.94% on the day as on 12:44 IST on the NSE. The stock is up 20.04% in last one year as compared...

Read more →

Stock Radar: Pharma stocks in focus! Laurus Labs looking attractive after 10% fall from 52-week high

(14 Oct 2024)

Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity for short-term...

Read more →

Stock Market Live Updates 11 October 2024: Stock to buy today: Laurus Labs (₹465)

(11 Oct 2024)

Sensex, Nifty, Share Price LIVE: The stock of Laurus Labs depreciated in the second half of September. It extended the downswing in the...

Read more →

Stock to buy today: Laurus Labs (₹465)

(11 Oct 2024)

Laurus Labs stock analysis: Support at ₹430, expected to rally to ₹530, buy at ₹465, stop-loss at ₹420.

Read more →

Shares to buy or sell: Rajesh Palviya of Axis Securities suggests these three stocks to buy, hold and accumulate today | Stock Market News

(11 Oct 2024)

Shares to buy or sell: Rajesh Palviya has recommended to buy, hold, and accumulate Laurus Labs Ltd, Polycab India Ltd, and Siemens Ltd.

Read more →

Laurus Labs' Stock Declines by -3.63% on October 7th, Underperforms Sector Average

(11 Oct 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, saw a decline of -3.63% in its stock price on October 7th, 2024.

Read more →

Laurus Labs Ltd gains for third straight session

(10 Oct 2024)

Laurus Labs Ltd is quoting at Rs 461.2, up 1.61% on the day as on 12:49 IST on the NSE. The stock is up 15.21% in last one year as compared...

Read more →

Stocks To Buy: Axis Direct recommends buying these 5 stocks for 5-15 days | Check targets, stop losses

(10 Oct 2024)

Axis Direct Top Stocks: Ahead of the market opening on Friday, Axis Direct picked five stocks that can generate profits in 5 to 15 days.

Read more →

Laurus Labs' Stock Sees 3.02% Increase and 'Hold' Recommendation from MarketsMOJO

(09 Oct 2024)

Laurus Labs, a leading pharmaceutical company in the largecap industry, saw a 3.02% increase in its stock price on October 9th, 2024.

Read more →

Laurus Labs Share price and Fundamental Analysis

(07 Oct 2024)

Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active...

Read more →

Laurus Labs - M&M, L&T Finance among 5 stocks with short buildup

(06 Oct 2024)

OI change on October 4: 1.07%Stock price change: -3.62% Laurus Labs.

Read more →

Laurus Labs: Potential Growth Opportunities Priced In

(05 Oct 2024)

Laurus Labs has seen significant stock volatility since its IPO in 2016, surging during the pandemic but dropping 60% from its peak as...

Read more →

Laurus Labs Limited Appoints Ramesh Subrahmanian as A Non-Executive Independent Director

(03 Oct 2024)

Laurus Labs Limited passed a resolution through Postal Ballot on October 3, 2024, appointment of Mr. Ramesh Subrahmanian as a Non-executive...

Read more →

Visakhapatnam: Govt appointed high-level panel visits SEZ

(26 Sep 2024)

Following the inspections, a meeting was convened at Laurus Labs Unit-II where officials gave a power point presentation detailing the...

Read more →

Laurus Labs (NSE:LAURUSLABS) sheds 5.9% this week, as yearly returns fall more in line with earnings growth

(24 Sep 2024)

Long term investing can be life changing when you buy and hold the truly great businesses. While not every stock...

Read more →

Laurus Labs inaugrates new RnD center at Telangana

(20 Sep 2024)

Hyderabad: Laurus Labs Ltd. a research and development driven pharmaceutical and biotech company in India has announced the inauguration of...

Read more →

Laurus Labs Ltd drops for fifth straight session

(19 Sep 2024)

Laurus Labs Ltd is quoting at Rs 463.95, down 4.42% on the day as on 13:19 IST on the NSE. The stock jumped 17.43% in last one year as...

Read more →

Laurus Labs inaugurates new R&D facility at IKP Knowledge Park

(19 Sep 2024)

Laurus Labs an R&D-driven pharmaceutical and biotech company in India has inaugurated a new R&D center at IKP Knowledge Park, Plot No DS15,...

Read more →

LAURUS LABS Share Price Today Down 4%

(18 Sep 2024)

LAURUS LABS share price has plunged 4% and is presently trading at Rs 482.9. Meanwhile, the BSE HEALTHCARE index is at 43,772.1 (down 1.2%).

Read more →

Laurus Labs and 3GV unveil cutting-edge life sciences facility in Telangana’s Genome Valley

(17 Sep 2024)

Telangana Minister inaugurates cutting-edge life sciences facilities, creating thousands of jobs and boosting state's biotech industry.

Read more →

Telangana: Laurus Labs and 3GV unveil cutting-edge life sciences facility

(17 Sep 2024)

Telangana Minister for IT & Industries Duddila Sridhar Babu on Monday inaugurated a new facility of Laurus Labs and 3GV, a multi-tenanted...

Read more →

Laurus Labs Sets Up Rs 250-Cr R&D Centre

(17 Sep 2024)

Hyderabad: Laurus Labs Ltd, a research and development (R&D)-driven pharmaceutical and biotech company, on Monday announced the inauguration...

Read more →

Laurus Labs unveils ₹250 crore R&D facility in Telangana

(16 Sep 2024)

Laurus Labs inaugurates new R&D facility in Telangana, investing ₹250 crore, creating jobs, and advancing healthcare innovation.

Read more →

Laurus Labs inaugurates new R&D center at IKP Knowledge Park

(16 Sep 2024)

Laurus Labs announced the inauguration of its state of the art new R&D center at IKP Knowledge Park, Plot No DS15, Kolthur Shamirpet Medchal...

Read more →

Laurus Labs Hyderabad facility successfully completes USFDA audit

(16 Sep 2024)

Hyderabad: Laurus Labs Ltd., a research and development driven pharmaceutical and biotech company in India has announced the successful...

Read more →

Laurus Labs sets up new R&D centre in Hyderabad at Rs 250 crore investment

(16 Sep 2024)

India Business News: Laurus Labs Ltd has launched a new R&D facility in Genome Valley, Hyderabad, with an investment of Rs 250 crore.

Read more →

Laurus Labs sets up ₹250 crore R&D centre in Hyderabad’s Genome Valley

(16 Sep 2024)

Laurus Labs opens state-of-the-art R&D centre in Hyderabad's Genome Valley, investing ₹250 crore for innovation and job creation.

Read more →

Laurus Labs inaugurates Rs. 250 crore R&D facility in Telangana

(16 Sep 2024)

Laurus Labs Ltd., a leading research and development driven pharmaceutical and biotech company in India has announced the inauguration of...

Read more →

Laurus Labs opens new R&D facility in IKP Knowledge Park, Hyderabad

(16 Sep 2024)

Laurus Labs has inaugurated a new R&D facility at IKP Knowledge Park near Hyderabad, investing Rs 250 crore. The 200000 square foot center...

Read more →

Minister, Life Sciences industry leaders discuss upgrades to Genome Valley

(16 Sep 2024)

Genome Valley has been at the heart of Telangana transformation over the past two decades into a premier destination for life sciences,...

Read more →

USFDA audit nod for Laurus

(14 Sep 2024)

Hyderabad: Biopharma player Laurus Labs Ltd on Friday informed the bourses that its active pharmaceutical ingredients (API) manufacturing...

Read more →

USFDA concludes audit for Laurus Labs’ API manufacturing facility at Hyderabad with zero Form 483 observations

(14 Sep 2024)

The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices.

Read more →

Laurus Labs Hyderabad unit clears USFDA inspection

(14 Sep 2024)

The inspection concluded with zero 483 observations by the US drug regulator. The pharmaceutical company said that its API manufacturing...

Read more →

API unit of Laurus Labs in Hyderabad completes US FDA audit

(13 Sep 2024)

Drugmaker Laurus Labs' active pharmaceutical ingredients (API) manufacturing facility in Hyderabad's Genome Valley has completed an audit of...

Read more →

Laurus Labs Hyd API unit completes USFDA inspection

(13 Sep 2024)

HYDERABAD: Biopharma player Laurus Labs Ltd on Friday informed the bourses that its active pharmaceutical ingredients (API) manufacturing...

Read more →

Stock market today: Trade setup for Nifty 50 to global markets, five stocks to buy or sell on Wednesday — Sept 11 | Stock Market News

(11 Sep 2024)

Stocks to buy todaty: Experts have recommended five shares to buy today — Inox Wind, Laurus Labs, Indraprastha Gas, MTAR Technologies,...

Read more →

Laurus Labs Ltd up for third straight session

(11 Sep 2024)

Laurus Labs Ltd is quoting at Rs 512, up 1.05% on the day as on 12:49 IST on the NSE. The stock is up 33.3% in last one year as compared to...

Read more →

US House passes Biosecure Act - How will it impact Indian Pharma

(10 Sep 2024)

These latest developments put the spotlight on Indian Pharma companies like Laurus Labs, Neuland Laboratories, Syngene and Piramal Pharma.

Read more →

Laurus Labs, Piramal Pharma, Syngene hit 52-week high after the US House passes Biosecure Act; here is why

(10 Sep 2024)

It was the first floor vote for the Biosecure Act, which would prohibit federal contracts with targeted firms and those that do business...

Read more →

LAURUS LABS Share Price Today Up 4%

(10 Sep 2024)

Real-time updates on LAURUS LABS share price. Check out the detailed analysis of the company in this live blog.

Read more →

US Passes Biosecure Act — A Game Changer For Indian Pharma

(10 Sep 2024)

In a significant development for the global pharmaceutical industry, the US has enacted the Biosecure Act, which bans American companies...

Read more →

Traders Diary: Buy, sell or hold strategy on ICICI Bank, Tata Power, HUL, Dixon Tech, Laurus Labs, over a d...

(10 Sep 2024)

Check out the complete list of stocks on analysts Kushal Gupta and Ashish Chaturvedi's radar. Get more Stocks News and Business News on Zee...

Read more →

Laurus Labs shares are near 52-week high levels; What should you do?

(06 Sep 2024)

Shares of Laurus Labs Ltd. are seeing some profit booking on Friday after a three-day surge with shares trading with losses of over 1%.

Read more →

Laurus Labs Ltd soars 4.39%

(05 Sep 2024)

Laurus Labs Ltd is quoting at Rs 496.5, up 4.39% on the day as on 12:49 IST on the NSE. The stock is up 21.9% in last one year as compared...

Read more →

Laurus Labs - Biocon, Syngene International among 5 stocks with long buildup

(05 Sep 2024)

OI change on September 5: 0.06%Change in stock price: 1.97% Laurus Labs.

Read more →

shares to buy and sellt oday intradat: stocks to buy: Titan, BHEL, Federal Bank city union bank laurus labs targets stop loss nse nifty bse sensex

(04 Sep 2024)

On the top analysts' 'buy' list are stocks such as Titan (TITAN), Bharat Heavy Electricals Ltd (BHEL), and Federal Bank (FEDERALBNK).

Read more →

Stock to Buy Today: 2 September 2024 - Laurus Labs (₹469.90): BUY

(02 Sep 2024)

Stocks to buy today, 2 September 2024: Buy Laurus Labs - Short-term bullish outlook for Laurus Labs, with potential to rise to ₹500;...

Read more →

Laurus Labs - Vodafone Idea, Sun TV among 5 stocks with long unwinding

(02 Sep 2024)

OI change on September 2: -0.33%Change in stock price: -1.73% Laurus Labs.

Read more →

Laurus Labs - Concurrent Gainers: These 8 midcap stocks gained for 5 days in a row

(31 Aug 2024)

5-Day Gain: 5% | Previous Close: Rs 470 Laurus Labs.

Read more →

Top China Plus One Manufacturing Companies in India

(31 Aug 2024)

With global manufacturing shifting beyond China, these five stocks are poised to benefit.

Read more →

2 stocks Hemang Jani is bullish on from pharma sector

(28 Aug 2024)

So, I do think that be it the largecap generic-focused companies like Sun, Dr Reddys, Cipla, or some of the API-based companies whether it...

Read more →

US Biosecure Act: Impact on Indian pharma companies

(28 Aug 2024)

According to Sibaji Biswas, ED & CFO, the Syngene International US Biosecure Act is a tangible opportunity for Indian companies.

Read more →

Laurus Labs Limited (NSE:LAURUSLABS) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

(27 Aug 2024)

Most readers would already know that Laurus Labs' (NSE:LAURUSLABS) stock increased by 2.6% over the past week. Given...

Read more →

Broader market outperforms; pharma shares in demand

(27 Aug 2024)

At 10:30 IST, the barometer index, the S&P BSE Sensex was down 31.70 points or 0.04% to 81659.50. The Nifty 50 index lost 14.30 points or...

Read more →

Laurus Labs - Deepak Nitrite, SBI Card among 5 stocks with long buildup

(27 Aug 2024)

OI change on August 27: 3.99%Change in stock price: 1.73% Laurus Labs.

Read more →

LAURUSLABS Outlook for the Week (August 26, 2024 – August 30, 2024)

(23 Aug 2024)

Technically, Laurus Labs share price will see immediate support at 431.55 and immediate resistance would be seen at 457.30.

Read more →

Laurus Labs Ltd spurts 1.39%, up for five straight sessions

(21 Aug 2024)

Laurus Labs Ltd is quoting at Rs 443.5, up 1.39% on the day as on 12:44 IST on the NSE. The stock is up 13.35% in last one year as compared...

Read more →

Laurus Labs Ltd rises for third consecutive session

(19 Aug 2024)

Laurus Labs Ltd is quoting at Rs 435.5, up 1.4% on the day as on 12:49 IST on the NSE. The stock is up 12.03% in last one year as compared...

Read more →

F&O stocks in focus: Long buildup seen in Naukri, Voltas, Laurus Labs

(16 Aug 2024)

Stocks with long buildup in August series: Key levels to track on Voltas, Naukri and Laurus Labs as these stocks could potentially gain up...

Read more →

LAURUS LABS Share Price Today Up 5%

(14 Aug 2024)

Real-time updates on LAURUS LABS share price. Check out the detailed analysis of the company in this live blog.

Read more →

Stock Radar: Laurus Labs likely to find support above lower band of rectangular pattern; time to buy?

(13 Aug 2024)

Laurus Labs Ltd stock dropped by over 10% from its peak in July 2024 but found support above the 200-day EMA. Experts predicted a potential...

Read more →

Laurus Labs Ltd soars 2.21%, Gains for third straight session

(30 Jul 2024)

Laurus Labs Ltd is quoting at Rs 460.95, up 2.21% on the day as on 12:49 IST on the NSE. The stock is up 30.95% in last one year as compared...

Read more →

Pharma player Laurus net profit falls 48% in Q1 2024

(29 Jul 2024)

Read about the 48% decline in Laurus Labs' net profit in the first quarter of 2024. Explore the reasons behind the decrease and the...

Read more →

Laurus Labs First Quarter 2025 Earnings: Misses Expectations

(27 Jul 2024)

Laurus Labs ( NSE:LAURUSLABS ) First Quarter 2025 Results Key Financial Results Revenue: ₹12.0b (up 1.3% from 1Q 2024...

Read more →

Technical Analysis: Brigade Enterprises, Laurus Labs and Muthoot Finance

(27 Jul 2024)

Brigade Enterprises has rebounded from the strong support at ₹1180 and could rally to ₹1600 in the coming weeks.

Read more →

Hot stocks: Brokerage view on Ramco Cements, Tech Mahindra, Laurus Labs, Syngene and Cyient

(26 Jul 2024)

Citi has maintained a sell call on Ramco Cements, raising the target price to Rs 750 from Rs 735. Despite stable EBITDA per ton, Ramco has...

Read more →

Laurus Labs Consolidated June 2024 Net Sales at Rs 1,194.91 crore, up 1.11% Y-o-Y

(26 Jul 2024)

Quarterly Net Profit at Rs. 12.51 crore in June 2024 down 49.66% from Rs. 24.85 crore in June 2023. EBITDA stands at Rs. 173.71 crore in...

Read more →

Laurus Labs Q1 profit drops by 48% to Rs 13 cr in FY25

(26 Jul 2024)

Hyderabad: City-based Laurus Labs Ltd, a research and development-driven pharmaceutical and biotech company announced its first quarter...

Read more →

Laurus Labs posts Q1 FY25 consolidated PAT at Rs. 12.51 Cr

(26 Jul 2024)

Laurus Labs Limited has reported consolidated financial results for the period ended June 30, 2024. Laurus Labs has posted net profit of Rs.

Read more →

Buy Laurus Labs; target of Rs 505: Motilal Oswal

(26 Jul 2024)

Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 505 in its research report dated...

Read more →

Laurus Labs Q1 Results | FY25 guidance maintained, stock recovers from the lows

(25 Jul 2024)

Shares of Laurus Labs Ltd. recovered from the day's low of ₹418.05 after the pharmaceutical company said that it remains committed to the...

Read more →

Laurus Labs Q1 Results: Company's Net Profit Falls 48% Amid High Margins

(25 Jul 2024)

Laurus Labs Ltd. reported Q1 FY25 revenues of Rs 1195 crore, up 1% year-over-year. Gross margins improved to 55.1%, but net profit fell by...

Read more →

Laurus Labs consolidated net profit declines 49.66% in the June 2024 quarter

(25 Jul 2024)

Net profit of Laurus Labs declined 49.66% to Rs 12.51 crore in the quarter ended June 2024 as against Rs 24.85 crore during the previous quarter ended June...

Read more →

Laurus Labs Q1 net slumps to ₹13 crore on lower revenue

(25 Jul 2024)

Laurus Labs reports 53% profit decline in Q1, focusing on growth in Oncology API and CDMO opportunities.

Read more →

Q1 Results 2024: Tech Mahindra, Nestle India, DLF, Ashok Leyland among others to report Q1 earnings today

(25 Jul 2024)

Q1 Results 2024-25: Today, companies like Tech Mahindra, Nestle India, DLF, Adani Green Energy Limited, Canara Bank, Ashok Leyland, Mphasis,...

Read more →

Board of Laurus Labs appoints director

(25 Jul 2024)

The Board of Laurus Labs at its meeting held on Ramesh Subrahmanian (DIN: 02933019) as an Additional Director in the capacity of Independent...

Read more →

Laurus Labs, Balrampur Chini Mills among 5 stocks with long unwinding

(12 Jul 2024)

Long unwinding refers to the selling of positions or stocks owned for a longer period either to book profit or to exit it in anticipation of...

Read more →

Top Stock Recommendations: Sagar Doshi of Nuvama suggests Laurus Labs, Balrampur Chini, and Hindalco today | Stock Market News

(10 Jul 2024)

Top Stock Recommendations: Sagar Doshi of Nuvama Professional Clients Group recommends these three stocks today - Laurus Labs Ltd,...

Read more →

Stock to buy today: Laurus Labs (₹437.6)

(08 Jul 2024)

Laurus Labs stock analysis: Potential rally to ₹475, buy at ₹437, stop-loss at ₹418, liquidate at ₹475.

Read more →

Stocks in focus: Rajesh Palviya of Axis Securities recommends Laurus Labs, Lupin, and Rites today | Stock Market News

(08 Jul 2024)

Stocks in focus: Rajesh Palviya has recommended to buy, hold, and accumulate Laurus Labs Ltd, Lupin Ltd, and Rites Ltd today.

Read more →

Laurus Labs edges lower after CARE Ratings downgrades rating outlook to 'negative'

(08 Jul 2024)

Laurus Labs fell 1.54% to Rs 427.85 after CARE Ratings revised its outlook on the long-term credit facilities of the company to 'negative'...

Read more →

Here's Why It's Unlikely That Laurus Labs Limited's (NSE:LAURUSLABS) CEO Will See A Pay Rise This Year

(06 Jul 2024)

Laurus Labs' Annual General Meeting to take place on 11th of July; CEO Satyanarayana Chava's total compensation includes salary of ₹108.6m...

Read more →

Laurus Labs Limited's (NSE:LAURUSLABS) Price In Tune With Revenues

(01 Jul 2024)

When close to half the companies in the Pharmaceuticals industry in India have price-to-sales ratios (or "P/S") below 2.8x, you may consider...

Read more →

Laurus Labs Ltd up for third consecutive session

(01 Jul 2024)

Laurus Labs Ltd is quoting at Rs 435.4, up 1.07% on the day as on 12:49 IST on the NSE. The stock is up 21.96% in last one year as compared...

Read more →

Briefs: Family Care Hospitals, Laurus Labs and Bafna Pharmaceuticals

(01 Jul 2024)

Family Care Hospitals to acquire property for expansion. In line with its growth and expansion plans, Family Care Hospitals Limited has...

Read more →

Volumes spurt at Laurus Labs Ltd counter

(01 Jul 2024)

Laurus Labs Ltd notched up volume of 2.17 lakh shares by 10:47 IST on BSE, a 5.4 fold spurt over two-week average daily volume of 40094...

Read more →

Laurus Labs' AP unit gets USFDA letter for deviating from Good Manufacturing Practices

(19 Jun 2024)

Shares of Laurus Labs Ltd. were trading with losses of 1% on Friday (May 24). The pharma company has received an 'untitled' letter dated May...

Read more →

Laurus Labs CEO confident of strong growth in CDMO business this year

(28 May 2024)

Satyanarayana Chava, Founder and CEO of Laurus Labs, explained that the CDMO business is highly variable and cannot be assessed on a...

Read more →

Dividend stocks: Laurus Labs shares to trade ex-dividend today | Stock Market News

(08 May 2024)

Dividend stocks: Shares of Laurus Labs Ltd will be in focus when the stock market opens on Wednesday, May 8.

Read more →

KRChoksey upgrades rating on Laurus Labs stock to 'Buy', sees further upside

(29 Apr 2024)

Net profit for the quarter fell 26 per cent year-on-year to Rs 76 crore, compared to Rs 103 crore last year.

Read more →

Buy Laurus Labs, target price Rs 480: Motilal Oswal

(26 Apr 2024)

Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 23412.68 Crore) operating in...

Read more →

Laurus Labs: CDMO services key to improved prospects, say analysts

(26 Apr 2024)

Contract development and manufacturing organisation (CDMO) services could hold the key to better prospects for Laurus Labs, analysts said...

Read more →

Laurus Labs slides after Q4 PAT tumbles 26% YoY to 76 cr

(25 Apr 2024)

Laurus Labs declined 2.09% to Rs 425.30 after the company's consolidated net profit dropped 26.58% to Rs 75.61 crore in Q4 FY24 as compared...

Read more →

Laurus Labs Q4 earnings: Net profit slips 25%; stock ends lower

(25 Apr 2024)

Pharma firm Laurus Labs reported a 25 percent fall in net profit for the March 2024 quarter. Net profit slipped to Rs 76 crore in the March...

Read more →

Laurus Labs shares may fall 23% in 12 months as Goldman Sachs finds risk-reward unfavourable

(12 Apr 2024)

Shares of Laurus Labs Ltd. is may fall as much as 23% over the next 12 months, according to brokerage firm Goldman Sachs.

Read more →

Laurus Labs shares may fall 23% in 12 months, says Goldman Sachs citing a skewed risk-reward

(12 Apr 2024)

Shares of Laurus Labs Ltd. is may fall as much as 23% over the next 12 months, according to brokerage firm Goldman Sachs.

Read more →

Laurus Labs Ltd spurts 0.01%, gains for five straight sessions

(04 Apr 2024)

Laurus Labs Ltd is quoting at Rs 439.9, up 0.01% on the day as on 12:44 IST on the NSE. The stock is up 43.85% in last one year as compared...

Read more →

How Satyanarayana Chava converted Laurus Labs into a leading integrated pharma company

(04 Apr 2024)

Since founding Laurus Labs in 2005, CEO Satyanarayana Chava has overseen a series of transformations that has helped the firm become an...

Read more →

Laurus Labs Share Price

(28 Mar 2024)

Laurus Labs Ltd Share Price, 22-07-2024: Get Laurus Labs Ltd latest news on BSE/NSE stock price live updates, Laurus Labs Ltd financial results and overview...

Read more →

Laurus Labs, Slovenia’s Krka to set up pharma JV in Hyderabad

(26 Jan 2024)

Drugmaker Laurus Labs and Slovenia's generic pharmaceutical firm Krka have decided to set up a joint venture company in Hyderabad to produce...

Read more →